Research Article
Volume 7 Issue 8 - 2022
The Correlation of Intratumoral Flt-4 Positive Lymphatic Vessels with the Expression of iNOS and VEGF-C in Canine Mammary Gland Tumor
Parin Suwannaprapha*, Tawewan Issarakura Na Ayudhada and Panop Wilainam
Department of Preclinic and Applied Animal Science, Faculty of Veterinary Science, Mahidol University, Thailand
*Corresponding Author: Parin Suwannaprapha, Department of Pre-Clinic and Applied Animal Sciences, Faculty of Veterinary Science, Mahidol University, Salaya Campus, Phutthamonthon, Nakhonpathom, Thailand.
Received: June 30, 2022; Published: July 27, 2022


Vascular endothelial growth factor-C (VEGF-C) and iNOS are considered to be a potentially lymphangiogenic and can selectively induce hyperplasia of the lymphatic vasculature. In this study, we aimed to clarify the relation between expression of VEGF-C and iNOS with Flt-4, lymphatic vessel marker, to investigate the intralymphatic tumor growth in canine mammary gland tumor by immunohistochemical method. Using the specific polyclonal antibodies, VEGF-C and iNOS immunolabeled cells were count in benign and malignant canine mammary gland neoplasm. All cases showed some tumor cell positive for VEGF-C and iNOS, and the staining pattern was seen predominantly cytoplasmic. The percentage of VEGF-C and iNOS positive cells ranged from 52.3% to 81.6% and 71.8% to 94.4%, respectively. Lymphatic vessel was investigated by the expression of Flt-4 in lymphatic endothelium and the result shows percentage number of lymph vessel among 15.5% - 37.7%. Although the percentage of Flt-4 positive lymph vessel, VEGF-C and iNOS positive cell in malignant neoplasm were produced in higher amounts than the benign neoplasm, there was highly significant difference (p < 0.05) among neoplastic group. Moreover, the numbers of VEGF-C, iNOS positive cells and tumor lymphatic vessels were positive correlated with each other for both benign and malignant tumor (p  0.01). This present study suggests that the upregulation of VEGF-C, iNOS in canine mammary gland tumors was interconnected with the intralymphatic tumor growth..

Keywords: VEGF-C; iNOS; Flt-4; Lymphatic Vessel Density; Canine Mammary Gland Tumor


  1. Anadol E., et al. “Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade”. Acta Veterinaria Hungarica3 (2017): 382-393.
  2. Burke AJ., et al. “The yin and yang of nitric oxide in cancer progression”. Carcinogenesis3 (2013): 503-512.
  3. Decio A., et al. “Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms”. The American Journal of Pathology 184 (2014): 1050-1061.
  4. Franchi A., et al. “Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor‐C expression in head and neck squamous cell carcinoma”. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland3 (2006): 439-445.
  5. Garcia EA., et al. “Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions”. Endocrine Pathology2 (2010): 101-107.
  6. Gomes FG., et al. “Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/ microenvironmental signaling mechanisms”. Life Sciences 92 (2013): 101-107.
  7. Hao Yu., et al. “The role of VEGF-C-D and Flt-4 in the lymphatic metastasis of early stage invasive cervical carcinoma”. Journal of Experimental and Clinical Cancer Research 28 (2009): 98.
  8. Karadayı N., et al. “Inducible nitric oxide synthase expression in gastric adenocarcinoma: impact on lymphangiogenesis and lymphatic metastasis”. Diagnostic Pathology1 (2013): 151.
  9. Lahdenranta J., et al. “Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis”. Cancer Research7 (2009): 2801-2808.
  10. Massi D., et al. “Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis”. Modern Pathology1 (2009): 21.
  11. Nakamura Y., et al. “Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis”. Clinical Cancer Research4 (2006): 1201-1207.
  12. Niu XJ., et al. “Relationship between inducible nitric oxide synthase expression and angiogenesis in primary gallbladder carcinoma tissue”. World Journal of Gastroenterology 10 (2004): 725-728.
  13. Pan Z., et al. “VEGF-C is positively associated with lymphangiogenesis and lymphatic metastasis in rectal cancer”. International Journal of Clinical and Experimental Pathology3 (2018): 1777-1783.
  14. Ranganathan S., et al. “Significance of twist and iNOS expression in human breast carcinoma”. Molecular and Cellular Biochemistry 412 (2016): 41-47.
  15. Raposo‐Ferreira TM., et al. “Evaluation of vascular endothelial growth factor gene and protein expression in canine metastatic mammary carcinomas”. Microscopy Research and Technique11 (2016): 1097-1104.
  16. Rauniyar K., et al. “Biology of vascular endothelial growth factor C in the morphogenesis of lymphatic vessels”. Frontiers in Bioengineering and Biotechnology 6 (2018): 7.
  17. Shigetomi S., et al. “VEGF-C/Flt-4 axis in tumor cells contributes to the progression of oral squamous cell carcinoma via upregulating VEGF-C itself and contactin-1 in an autocrine manner”. American Journal of Cancer Research10 (2018): 2046.
  18. Singh PP., et al. “Intratumoural and peritumoural lymphangiogenesis in canine mammary tumour linked to tumour spread and poor survival”. Current Science7 (2018): 1312.
  19. Singh S and Gupta AK. “Nitric oxide: role in tumour biology and iNOS/NObased anticancer therapies”. Cancer Chemotherapy and Pharmacology6 (2011): 1211-1224.
  20. Sleeckx N. Angiogenesis and lymphangiogenesis in canine mammary tumours (Doctoral dissertation, University of Antwerp) (2013).
  21. Tascene N., et al. “Serum neopterin, sialic acid and nitric oxide levels in dogs with malignant mammary tumours”. Veterinary and Comparative Oncology 10 (2012): 155-159.
  22. Zafirellis K., et al. “Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer”. Acta Pathologica, Microbiologica, Et Immunologica Scandinavica 118 (2010): 115-124.
  23. Zhang W., et al. “Inducible nitric oxide synthase expression correlates with angiogenesis,lymphangiogenesis, and poor prognosis in gastric cancer patients”. Human Pathology9 (2011): 1275-1282.
  24. Zhao YC., et al. “Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients”. World Journal of Surgical Oncology1 (2012): 165.
  25. Ziche M and Morbidelli L. “Molecular regulation of tumour angiogenesis by nitric oxide”. European Cytokine Network4 (2009): 164-170.
Citation: Parin Suwannaprapha., et al. ““The Correlation of Intratumoral Flt-4 Positive Lymphatic Vessels with the Expression of iNOS and VEGF-C in Canine Mammary Gland Tumor”. EC Veterinary Science 7.8 (2022): 09-15.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 23, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.